Summary of The Cigna Group Conference Call Company Overview - **Company**: The Cigna Group (NYSE: CI) - **Date**: May 15, 2024 - **Participants**: Brian Evanko (CFO and CEO of Cigna Healthcare), Hasan Riaz, Ralph Giacobbe Key Points Industry and Utilization Trends - **Utilization Levels**: Strong levels of utilization were observed in 2023 across Cigna Healthcare's health plan book, which was anticipated in pricing and projections [4][5] - **Medicare Advantage**: The Medicare Advantage segment, with approximately 600,000 lives, showed strong utilization levels consistent with commercial employer experiences [8] - **Commercial Growth**: Cigna Healthcare's commercial employer business is a cornerstone, contributing about 40% of income, with expectations for growth in the under 500 employer size segment [11][12] Financial Performance - **Revenue Growth**: Cigna Healthcare experienced strong revenue growth in 2023, with better-than-expected MCR performance and income in Q1 2024 [5][6] - **Membership Trends**: The Select segment (employers with 50-500 employees) is expected to see intra-year growth, while larger segments experienced some losses due to known client departures [15][16][20] - **Market Share**: Cigna's market share in the Select segment increased from 5% to 7% over five years, with aspirations to reach double digits [12] Strategic Decisions - **Divestiture of Medicare Business**: Cigna is divesting its Medicare business to HCSC, with a closing date expected in early 2025. This decision is based on the business's relatively small size in Cigna's portfolio and the resources required to scale it [22][23] - **Focus on Evernorth**: Evernorth, Cigna's health services platform, is divided into two segments: Specialty and Care Services, and Pharmacy Benefits Services, each contributing about 30% to total income [29][30] Growth Projections - **Earnings Growth**: Cigna expects average annual income growth of 7% to 10%, with individual exchanges projected to grow 10% to 15% [54] - **Specialty Pharmacy Market**: The specialty pharmacy market is expected to grow significantly due to pharmaceutical innovations, with Cigna's Accredo Specialty Pharmacy holding about 20% market share [37][38] Competitive Landscape - **Market Positioning**: Cigna does not view the current market as increasingly competitive, citing rational pricing among competitors [18] - **Behavioral Health Demand**: There is a growing demand for behavioral health services, which Cigna aims to capitalize on [39] Capital Deployment - **Share Repurchase**: Cigna plans to utilize a significant portion of its discretionary cash flow for share repurchase, with a commitment of at least $5 billion by mid-2024 [62] - **M&A Strategy**: Cigna sees M&A as a critical part of its capital deployment strategy, focusing on improving competitive positioning and expanding addressable markets [66][67] Risks and Challenges - **Potential Headwinds**: While no significant headwinds were identified, there is always a risk of higher-than-expected medical cost utilization and the need for strategic investments [60] Conclusion - **Overall Outlook**: Cigna is positioned for strong growth with a focus on its core businesses, strategic divestitures, and capitalizing on market opportunities in specialty pharmacy and behavioral health services [59][60]

Table of Contents As filed with the Securities and Exchange Commission on January 17, 2024 Registration No. 333-276348 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BrightSpring Health Services, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 8082 82-2956404 (I ...